Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
2.050
0.00 (0.00%)
Sep 18, 2025, 8:37 AM EDT - Market open

Innate Pharma Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
612.6251.949.5812.1156.16
Upgrade
Other Revenue
6.647.59.748.0912.5913.62
Upgrade
12.6420.1261.6457.6724.769.77
Upgrade
Revenue Growth (YoY)
-62.60%-67.36%6.88%133.47%-64.59%-18.34%
Upgrade
Cost of Revenue
51.9851.9856.0251.664749.71
Upgrade
Gross Profit
-39.34-31.865.626.01-22.320.07
Upgrade
Selling, General & Admin
19.919.7218.2922.4425.5218.99
Upgrade
Operating Expenses
11.3519.7218.2922.4425.5218.99
Upgrade
Operating Income
-50.69-51.58-12.67-16.43-47.831.08
Upgrade
Interest Expense
-1.31-0.57-0.64-0.29-0.31-0.34
Upgrade
Interest & Investment Income
2.442.443.180.550.330.56
Upgrade
Currency Exchange Gain (Loss)
-1.75-1.750.910.831.25-1.58
Upgrade
Other Non Operating Income (Expenses)
5.261.981.65-1.631.08-0.55
Upgrade
EBT Excluding Unusual Items
-46.05-49.47-7.57-16.97-45.48-0.83
Upgrade
Asset Writedown
----41--
Upgrade
Pretax Income
-46.05-49.47-7.57-57.97-45.48-0.83
Upgrade
Earnings From Continuing Operations
-46.05-49.47-7.57-57.97-45.48-0.83
Upgrade
Earnings From Discontinued Operations
----0.13-7.33-63.16
Upgrade
Net Income
-46.05-49.47-7.57-58.1-52.81-63.98
Upgrade
Net Income to Common
-46.05-49.47-7.57-58.1-52.81-63.98
Upgrade
Shares Outstanding (Basic)
848180808079
Upgrade
Shares Outstanding (Diluted)
848180808079
Upgrade
Shares Change (YoY)
4.15%0.74%1.02%0.12%0.77%17.97%
Upgrade
EPS (Basic)
-0.55-0.61-0.09-0.73-0.66-0.81
Upgrade
EPS (Diluted)
-0.55-0.61-0.09-0.73-0.66-0.81
Upgrade
Free Cash Flow
-41.26-7.29-32.91-19.69-59.39-52.67
Upgrade
Free Cash Flow Per Share
-0.49-0.09-0.41-0.25-0.75-0.67
Upgrade
Gross Margin
--158.34%9.12%10.42%-90.28%28.76%
Upgrade
Operating Margin
-401.15%-256.32%-20.55%-28.48%-193.60%1.55%
Upgrade
Profit Margin
-364.44%-245.87%-12.28%-100.74%-213.78%-91.70%
Upgrade
Free Cash Flow Margin
-326.54%-36.22%-53.39%-34.14%-240.40%-75.49%
Upgrade
EBITDA
-49.82-50.27-8.53-12.02-43.2313.31
Upgrade
EBITDA Margin
--249.86%-13.84%-20.84%-174.99%19.07%
Upgrade
D&A For EBITDA
0.871.34.144.414.612.23
Upgrade
EBIT
-50.69-51.58-12.67-16.43-47.831.08
Upgrade
EBIT Margin
--256.32%-20.55%-28.48%-193.60%1.55%
Upgrade
Revenue as Reported
12.6420.1261.6457.6724.769.77
Upgrade
Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q